BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2883647)

  • 21. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
    Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
    Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin-producing pancreatic endocrine tumour. Histological, ultrastructural and immunohistochemical study of a case.
    Kanavaros P; Hoang C; Le Bodic MF; Polivka M; Hautefeuille P
    Histol Histopathol; 1990 Jul; 5(3):325-8. PubMed ID: 1966880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
    White A; Tan K; Gray C; Roberts I; Ratcliffe JG
    Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
    Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
    Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of vasoactive intestinal peptide release in short-term culture of vasoactive intestinal peptide-producing tumor.
    Harty RF; Jain DK; McGuigan JE
    Gastroenterology; 1988 Feb; 94(2):513-8. PubMed ID: 2446951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
    Bloom SR; Polak JM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
    Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WDHA syndrome caused by VIP-producing ganglioneuroblastoma.
    Kudo K; Kitajima S; Munakata H; Yagihashi S
    J Pediatr Surg; 1982 Aug; 17(4):426-8. PubMed ID: 6288909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
    Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormones of the digestive system. II. Pathology].
    Vigouroux N; Thomas M
    Med Chir Dig; 1978; 7(4):289-302. PubMed ID: 209259
    [No Abstract]   [Full Text] [Related]  

  • 33. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
    Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
    Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic islet cell carcinoma with gastrin and vasoactive intestinal polypeptide production.
    Barragry TP; Wick MR; Delaney JP
    Arch Surg; 1985 Oct; 120(10):1178-81. PubMed ID: 2994597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
    Granuci P; Mahler RJ
    Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
    [No Abstract]   [Full Text] [Related]  

  • 38. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
    Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
    Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
    Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
    J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Watery diarrhea syndrome. Two unusual cases and further evidence that VIP is a humoral mediator.
    Cooperman AM; Desantis D; Winkelman E; Farmer R; Eversman J; Said S
    Ann Surg; 1978 Mar; 187(3):325-8. PubMed ID: 205179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.